Know Labs (KNWN) Stock Price, News & Analysis

Company Overview

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Key Stats

• Today's Range: $0.05 to $0.07
• 50-Day Range: $0.05 to $0.25
• 52-Week Range: $0.02 to $0.92
• Volume: 817,171 shs
• Average Volume: 3.98 million shs
• Market Capitalization: $7.78 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KNWN Stock Analysis - Frequently Asked Questions

How have KNWN shares performed this year?

Know Labs' stock was trading at $0.1721 at the beginning of the year. Since then, KNWN stock has decreased by 59.3% and is now trading at $0.07.
View the best growth stocks for 2025 here.

How were Know Labs' earnings last quarter?

Know Labs, Inc. (OTCMKTS:KNWN) issued its quarterly earnings data on Wednesday, August, 7th. The company reported ($0.04) EPS for the quarter. The firm had revenue of $0.38 million for the quarter.

How do I buy shares of Know Labs?

Shares of KNWN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Know Labs own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Know Labs investors own include Denali Therapeutics (DNLI), Co-Diagnostics (CODX), Home Depot (HD), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV) and iBio (IBIO).

Company Calendar

• Last Earnings: 8/07/2019
• Today: 2/05/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Business Services
• Industry: Measuring & controlling devices, not elsewhere classified
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: OTCMKTS:KNWN
• CUSIP: N/A
• CIK: 1074828
• Web: www.knowlabs.co
• Phone: (206) 903-1351
• Fax: 206-826-0451
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-16,580,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -405.50%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.60
• Quick Ratio: 0.60

Sales & Book Value

• Annual Sales: $4.36 million
• Price / Sales: 1.78
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.02) per share
• Price / Book: -3.50

Miscellaneous

• Outstanding Shares: 111,170,000
• Free Float: 93,157,000
• Market Cap: $7.78 million
• Optionable: Not Optionable
• Beta: 1.50